Chlorpromazine Recall: AvKare 100 mg
Announced 2026-03-04 · FDA
The FDA lists a recall of AvKARE chlorpromazine hydrochloride tablets, 100 mg, 50-count unit-dose cartons. The recall is due to the presence of a foreign substance and affects 2003 cartons. Lot numbers 47089 (Exp 12/31/25) and 47604 (Exp 03/31/26) are included in the recall.
| Brand | AvKARE |
|---|---|
| Product | chloroproMAZINE Hydrochloride Tablets, USP, 100 mg, 50 Tablets (5x10) unit dose carton, Rx only, Manufactured for: AvKare, Pulaski, TN, 38478, NDC 50268-165-15 |
| Reason | Presence of a foreign substance. |
| Severity | moderate |
| Units affected | 2003 cartons |
| Distribution | USA Nationwide |
| Agency | FDA |
| Recall / campaign no. | Lot # 47089, Exp 12/31/25; 47604, Exp 03/31/26 |
WHAT YOU SHOULD DO
- Check your packaging for Lot numbers 47089 or 47604 and their expiration dates.
- Do not use the recalled product.
- Visit AvKare’s website for recall instructions and return options.
- If you have used the product, contact your healthcare provider for guidance.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.